Medicare Advantage (MA) plans have decreased from 39 to 35 in 2027, causing about 1% of enrollees to lose prescription drug coverage. Part D subsidies are expiring, likely raising costs for half of recipients. Critics highlight MA's restrictive networks and cost issues, while supporters note its affordability, out-of-pocket caps, and extra benefits. Choosing between MA and traditional Medicare depends on individual health needs, provider access, and financial considerations.




